If you need more lookups,
subscriptions start at $34 USD/month.
Shefali Agarwal Location
Cambridge, MA, US
Shefali Agarwal Work
2025 -now President and CEO @
2021 -now Board Member @ Gritstone bio
2019 -now Board Member @ Fate therapeutics inc
2022 -2024 CEO and President @
2018 -2022 EVP Chief Medical and Development Officer @ Epizyme
2017 -2019 Lead GYN Oncology Advisor @
2013 -2017 Senior Medial Director, Clinical Lead on Niraparib Program @
2018 -2018 Non executive advisor @ SQZ Biotechnologies
2017 -2018 Chief Medical Officer @ SQZ Biotechnologies
2016 -2017 SVP, Head Of Clinical Development @
2011 -2013 Medical Director @
2010 -2011 Medical Director, CR,D @
2005 -2010 Ast Director, CR and D @
2003 -2006 Fellow Clinical Research @
1999 -1999 Medical Junior Resident @ Jain Medical Center
1998 -1999 Associate Medical Advisor @ Bestochem Formulations Ltd
Shefali Agarwal Education
The Johns Hopkins University School of Medicine 2000-2003
University of Maryland - Robert H. Smith School of Business
MIS (Information systems)
2000-2002
Bangalore University
MBBS (MBBS)
1993-2000
Shefali Agarwal Skills
Clinical Research
EDC
Oncology
Clinical Trials
Pharmaceutical Industry
Protocol
Infectious Diseases
Neurology
Strategic Planning
Drug Development
Project Management
CTMS
Clinical Development
Hematology
Medicine
Management
Data Analysis
Microsoft Office
Marketing
Shefali Agarwal Summary
Shefali Agarwal, based in Cambridge, MA, US, is currently a President and CEO at Sironax. Shefali Agarwal brings experience from previous roles at Gritstone bio, Fate therapeutics inc, Valerio Therapeutics and Epizyme. Shefali Agarwal holds a 2000 - 2003 The Johns Hopkins University School of Medicine. With a robust skill set that includes Clinical Research, EDC, Oncology, Clinical Trials, Pharmaceutical Industry and more. Shefali Agarwal has 4 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Shefali Agarwal?
Find contact details for 700 million professionals.